Ursolic acid in cancer prevention and treatment: Molecular targets, pharmacokinetics and clinical studies
MetadataShow full item record
Discovery of bioactive molecules and elucidation of their molecular mechanisms open up an enormous opportunity for the development of improved therapy for different inflammatory diseases, including cancer. Triterpenoids isolated several decades ago from various medicinal plants now seem to have a prominent role in the prevention and therapy of a variety of ailments and some have already entered Phase I clinical trials. One such important and highly investigated pentacyclic triterpenoid, ursolic acid has attracted great attention of late for its potential as a chemo preventive and chemotherapeutic agent in various types of cancer. Ursolic acid has been shown to target multiple pro inflammatory transcription factors, cell cycle proteins, growth factors, kinases, cytokines, chemokines, adhesion molecules, and inflammatory enzymes. These targets can potentially mediate the chemo preventive and therapeutic effects of ursolic acid by inhibiting the initiation, promotion and metastasis of cancer. This review not only summarizes the diverse molecular targets of ursolic acid, but also provides an insight into the various preclinical and clinical studies that have been performed in the last decade with this promising triterpenoid.
Showing items related by title, author, creator and subject.
Ursolic acid inhibits the initiation, progression of prostate cancer and prolongs the survival of TRAMP mice by modulating pro-inflammatory pathwaysShanmugam, M.; Ong, T.; Kumar, Alan Prem; Lun, C.; Ho, P.; Wong, P.; Hui, K.; Sethi, G. (2012)Prostate cancer is one of the leading causes of cancer death among men worldwide. In this study, using transgenic adenocarcinoma of mouse prostate (TRAMP) mice, the effect of diet enriched with 1% w/w ursolic acid (UA) ...
Redox-responsive chemosensitive polyspermine delivers ursolic acid targeting to human breast tumor cells: The depletion of intracellular GSH contents arouses chemosensitizing effectsJi, X.; Tang, Q.; Pang, P.; Wu, Jian-Ping; Kirk, Brett; Xu, J.; Ma, D.; Xue, W. (2018)Antitumor efficacy of ursolic acid (UA) is seriously limited due to its low hydrophilicity and needy bioavailability. To overcome these obstacles, chemosensitive polyspermine (CPSP) conjugated with UA and folic acid (FA) ...
Roy, N.; Deka, A.; Bordoloi, D.; Mishra, S.; Kumar, Alan Prem; Sethi, G.; Kunnumakkara, A. (2016)© 2016 Elsevier Ireland Ltd. Despite the extensive research carried out in the field of cancer therapeutics, cancer is one of the most dreadful diseases in the world with no definitive treatment to date. The key attributes ...